Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
59
PharmaCompass offers a list of Abrocitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Abrocitinib manufacturer or Abrocitinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Abrocitinib manufacturer or Abrocitinib supplier.
A compound 25 [PMID: 29298069] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of compound 25 [PMID: 29298069], including repackagers and relabelers. The FDA regulates compound 25 [PMID: 29298069] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. compound 25 [PMID: 29298069] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of compound 25 [PMID: 29298069] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A compound 25 [PMID: 29298069] supplier is an individual or a company that provides compound 25 [PMID: 29298069] active pharmaceutical ingredient (API) or compound 25 [PMID: 29298069] finished formulations upon request. The compound 25 [PMID: 29298069] suppliers may include compound 25 [PMID: 29298069] API manufacturers, exporters, distributors and traders.
click here to find a list of compound 25 [PMID: 29298069] suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A compound 25 [PMID: 29298069] DMF (Drug Master File) is a document detailing the whole manufacturing process of compound 25 [PMID: 29298069] active pharmaceutical ingredient (API) in detail. Different forms of compound 25 [PMID: 29298069] DMFs exist exist since differing nations have different regulations, such as compound 25 [PMID: 29298069] USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A compound 25 [PMID: 29298069] DMF submitted to regulatory agencies in the US is known as a USDMF. compound 25 [PMID: 29298069] USDMF includes data on compound 25 [PMID: 29298069]'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The compound 25 [PMID: 29298069] USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of compound 25 [PMID: 29298069] suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a compound 25 [PMID: 29298069] Drug Master File in Korea (compound 25 [PMID: 29298069] KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of compound 25 [PMID: 29298069]. The MFDS reviews the compound 25 [PMID: 29298069] KDMF as part of the drug registration process and uses the information provided in the compound 25 [PMID: 29298069] KDMF to evaluate the safety and efficacy of the drug.
After submitting a compound 25 [PMID: 29298069] KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their compound 25 [PMID: 29298069] API can apply through the Korea Drug Master File (KDMF).
click here to find a list of compound 25 [PMID: 29298069] suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing compound 25 [PMID: 29298069] as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for compound 25 [PMID: 29298069] API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture compound 25 [PMID: 29298069] as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain compound 25 [PMID: 29298069] and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a compound 25 [PMID: 29298069] NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of compound 25 [PMID: 29298069] suppliers with NDC on PharmaCompass.
compound 25 [PMID: 29298069] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of compound 25 [PMID: 29298069] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right compound 25 [PMID: 29298069] GMP manufacturer or compound 25 [PMID: 29298069] GMP API supplier for your needs.
A compound 25 [PMID: 29298069] CoA (Certificate of Analysis) is a formal document that attests to compound 25 [PMID: 29298069]'s compliance with compound 25 [PMID: 29298069] specifications and serves as a tool for batch-level quality control.
compound 25 [PMID: 29298069] CoA mostly includes findings from lab analyses of a specific batch. For each compound 25 [PMID: 29298069] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
compound 25 [PMID: 29298069] may be tested according to a variety of international standards, such as European Pharmacopoeia (compound 25 [PMID: 29298069] EP), compound 25 [PMID: 29298069] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (compound 25 [PMID: 29298069] USP).
